Cerebrolysin vs Citicoline
Two compounds given for stroke and cognitive decline, both with real trials — and both with a null result sitting at the center of the record.
Cerebrolysin
A porcine-brain-derived peptide mixture with a real but weak and mixed human trial record in stroke and dementia — not FDA-approved, and a recent Cochrane-style review found the evidence insufficient to recommend it.
Full Cerebrolysin evidence reviewCiticoline
CDP-choline, Cognizin
The best-tested compound on the nootropic shelf, and that is the problem: ICTUS in stroke and COBRIT in brain injury were both null, leaving open-label cognition data and two small manufacturer-linked trials in healthy people.
Full Citicoline evidence reviewSide by side
| Cerebrolysin | Citicoline | |
|---|---|---|
| Marketed for | Cognitive decline, stroke recovery, dementia | Memory, focus, brain health |
| Evidence grade | Clinical data | Clinical data |
| Family | mTOR & other | mTOR & other |
| Key human source | Cerebrolysin for acute ischemic stroke, Cochrane 2023 | ICTUS trial, Lancet 2012 |
marks a row where the two differ. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
Our verdict
Neither earns the confidence its marketing carries, and they fail differently. Citicoline is the best-tested compound on the nootropic shelf, which is precisely the problem: ICTUS in stroke and COBRIT in brain injury were both null, leaving open-label cognition data and two small manufacturer-linked trials in healthy people. Cerebrolysin, a porcine-brain-derived peptide mixture, has a real but weak and mixed record in stroke and dementia, is not FDA-approved, and a Cochrane review found the evidence insufficient to recommend it. Citicoline was tested properly and did not work; cerebrolysin has not been tested well enough to say.
Cerebrolysin fits if
You are reviewing it as the registered drug it is in the countries that license it, not as a supplement.
Citicoline fits if
You want the compound with the largest and cleanest trials behind it, and you read two null pivotal results as the answer.